Altimmune (ALT) PT Lowered to $11 at Citizens on Increased Dilutive Shares in 10-Q Filing
Tweet Send to a Friend
Citizens analyst Jonathan Wolleben lowered the price target on Altimmune (NASDAQ: ALT) to $11.00 (from $14.00) while maintaining a Market ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
